Tell me all common genetic diseases that can occur in pregnancy and especially in elderly pregnancy... Make a table if possible... Like investigations to diagnose or something..
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching the Web
common genetic diseases in pregnancy elderly advanced maternal age investigations diagnosis table
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
I now have comprehensive data from authoritative textbooks. Let me compile the full answer.
Here is a thorough breakdown of common genetic diseases in pregnancy, with particular focus on advanced maternal age (AMA, defined as ≥35 years), along with investigations to diagnose them.
Genetic Diseases in Pregnancy: Complete Reference Guide
What is Advanced Maternal Age (AMA)?
- AMA: ≥35 years at delivery
- Very Advanced Maternal Age (VAMA): ≥40 years
- Extremely Advanced Maternal Age (EAMA): ≥45 years
As maternal age increases, the risk of non-disjunction during meiosis rises, making chromosomal aneuploidies far more common. Single-gene disorders are NOT directly affected by maternal age - they depend on parental carrier status.
PART 1: Chromosomal Disorders (Age-Dependent - Risk Rises with AMA)
| Disease | Chromosomal Basis | Incidence / AMA Risk | Key Features | Screening Tests | Diagnostic Tests |
|---|---|---|---|---|---|
| Down Syndrome (Trisomy 21) | Extra chromosome 21 (95% non-disjunction, 4% translocation, 1% mosaic) | Age 20: 1/1500; Age 35: 1/400; Age 40: 1/100; Age 45: 1/30 | Hypotonia, flat facies, epicanthic folds, single palmar crease, intellectual disability, AV septal defects, increased Alzheimer risk | NIPT/cfDNA (99.7% sensitivity); Quad screen (AFP↓, hCG↑, uE↓, inhibin A↑); NT measurement + PAPP-A | CVS (11-13 weeks) or Amniocentesis (15-20 weeks) with karyotype or chromosomal microarray |
| Edwards Syndrome (Trisomy 18) | Extra chromosome 18 | Age 35: ~1/5000; Age 40: ~1/1000; sharp increase after 40 | Severe IUGR, clenched fists, rocker-bottom feet, VSD, omphalocele; 95% fetal loss, very poor prognosis | NIPT (97.9% sensitivity); Quad screen (AFP, hCG, uE all low); NT increased | CVS or Amniocentesis + karyotype |
| Patau Syndrome (Trisomy 13) | Extra chromosome 13 | ~1/10,000 live births; increases with age | Holoprosencephaly, cyclopia, polydactyly, cleft lip/palate, cardiac defects; 95% fetal loss | NIPT (99% sensitivity); Variable quad screen pattern | CVS or Amniocentesis + karyotype |
| Turner Syndrome (45,X) | Monosomy X | ~1/2500 female births; NOT strongly age-dependent | Short stature, webbed neck, streak gonads, coarctation of aorta, primary amenorrhea, infertility | NIPT can detect sex chromosome aneuploidies; Increased AFP on maternal serum screen | CVS or Amniocentesis + karyotype |
| Klinefelter Syndrome (47,XXY) | Extra X in males | ~1/500-1000 male births; NOT strongly age-dependent | Tall stature, small testes, infertility, gynecomastia, learning difficulties | NIPT sex chromosome panel | CVS or Amniocentesis + karyotype |
| Triple X Syndrome (47,XXX) | Extra X in females | ~1/1000 female births | Usually mild; tall stature, learning difficulties, ovarian failure possible | NIPT sex chromosome panel | Amniocentesis |
| 47,XYY Syndrome | Extra Y in males | ~1/1000 male births | Tall stature, behavioral issues; often asymptomatic | NIPT sex chromosome panel | Amniocentesis |
PART 2: Genomic Microdeletion/Microduplication Syndromes
These are NOT reliably age-dependent but are increasingly detectable by chromosomal microarray.
| Syndrome | Location | Features | Detection |
|---|---|---|---|
| DiGeorge / 22q11.2 Deletion | 22q11.2 | Conotruncal heart defects, cleft palate, immune deficiency, hypocalcemia, psychiatric risk | Microarray or NIPT (some platforms) |
| Angelman Syndrome | 15q11-q13 (mat deletion) | Severe intellectual disability, seizures, happy demeanor, absent speech | Microarray (amniocentesis/CVS) |
| Prader-Willi Syndrome | 15q11-q13 (pat deletion) | Neonatal hypotonia, hyperphagia, obesity, intellectual disability | Microarray (amniocentesis/CVS) |
| Williams-Beuren Syndrome | 7q11.23 deletion | Supravalvular aortic stenosis, elfin facies, intellectual disability | Microarray |
| Smith-Magenis Syndrome | 17p11.2 deletion | Intellectual disability, self-injurious behavior, sleep disturbance | Microarray |
| Cri-du-Chat Syndrome | 5p deletion | High-pitched cat-like cry, intellectual disability, microcephaly | Microarray or karyotype |
PART 3: Single-Gene (Mendelian) Disorders (Carrier Screening - NOT Age-Dependent)
These disorders are detected by carrier screening of parents, regardless of age.
| Disease | Inheritance | Affected Population | Features | Carrier Screening | Prenatal Diagnosis |
|---|---|---|---|---|---|
| Cystic Fibrosis | Autosomal Recessive | All (esp. Northern European) | Chronic lung disease, pancreatic insufficiency, male infertility | Maternal (then paternal if positive) cfDNA or blood-based CFTR mutation panel | CVS or amniocentesis with CFTR sequencing |
| Sickle Cell Disease | Autosomal Recessive | African, Mediterranean, Indian | Hemolytic anemia, vaso-occlusive crises, stroke | Hemoglobin electrophoresis; DNA mutation testing | CVS or amniocentesis; DNA analysis |
| Beta-Thalassemia | Autosomal Recessive | Mediterranean, Middle East, South Asia | Severe anemia, hepatosplenomegaly, bone changes | CBC (low MCV), Hb electrophoresis, HbA2 >3.5%; DNA | CVS or amniocentesis |
| Fragile X Syndrome | X-linked (CGG repeat expansion) | All; esp. family history of intellectual disability | Intellectual disability (most common inherited cause), autism features, macroorchidism | FMR1 CGG repeat testing (maternal DNA) | CVS or amniocentesis with FMR1 analysis |
| Spinal Muscular Atrophy (SMA) | Autosomal Recessive | All populations | Progressive muscle weakness, SMN1 deletion | SMN1 copy number analysis | CVS or amniocentesis with SMN1 testing |
| Phenylketonuria (PKU) | Autosomal Recessive | Northern European | Intellectual disability if untreated; maternal PKU causes fetal damage | Newborn screening (Guthrie/tandem MS); PAH gene carrier testing | CVS or amniocentesis for PAH mutations |
| Tay-Sachs Disease | Autosomal Recessive | Ashkenazi Jewish, French-Canadian | Neurodegeneration, cherry-red spot, death by age 4 | Hexosaminidase A enzyme assay + DNA | CVS or amniocentesis |
| Gaucher Disease | Autosomal Recessive | Ashkenazi Jewish | Hepatosplenomegaly, bone crises (Type 1 survivable) | Glucocerebrosidase enzyme assay + DNA | CVS/amniocentesis; glucocerebrosidase in leukocytes or fibroblasts |
PART 4: Summary of Prenatal Investigations
Screening Tests (Non-Invasive)
| Test | Timing | Detects | Sensitivity |
|---|---|---|---|
| NIPT / cfDNA (cell-free fetal DNA) | ≥10 weeks | T21, T18, T13, sex chromosome aneuploidies, some microdeletions | T21: ~99.7%; T18: ~97.9%; T13: ~99% |
| First Trimester Combined Screen | 11-13+6 weeks | T21, T18 | ~83-85% (with maternal age) |
| - NT (nuchal translucency) ultrasound | 11-13+6 weeks | T21, T18, cardiac defects | Part of combined screen |
| - PAPP-A (low in T21) | 10-13 weeks | T21 | Combined with NT: better |
| - Free β-hCG (high in T21) | 11-13 weeks | T21 | Combined marker |
| Quad Screen (2nd trimester) | 15-20 weeks | T21, T18, NTD | ~80% for T21 |
| - AFP | 15-20 weeks | ↓ in T21; ↑ in NTD, gastroschisis | - |
| - hCG | 15-20 weeks | ↑ in T21 | - |
| - Unconjugated estriol (uE3) | 15-20 weeks | ↓ in T21, T18 | - |
| - Dimeric Inhibin A | 15-20 weeks | ↑ in T21 | Relatively stable throughout 2nd trimester |
| Anomaly Ultrasound (Level II) | 18-22 weeks | Structural defects, soft markers for T21 | Variable |
| Carrier Screening Panel | Pre-pregnancy or 1st trimester | CF, SMA, Fragile X, hemoglobinopathies, etc. | Very high for specific mutations |
Diagnostic Tests (Invasive - Definitive)
| Test | Timing | What It Can Do | Procedure Risk |
|---|---|---|---|
| Chorionic Villus Sampling (CVS) | 11-13 weeks | Karyotype, microarray, specific gene mutations | ~0.5-1% miscarriage risk |
| Amniocentesis | ≥15 weeks | Karyotype, microarray, specific gene mutations, enzyme assays | ~0.5% miscarriage risk |
| Chromosomal Microarray (CMA) | On CVS/amnio samples | Detects microdeletions/duplications not seen on standard karyotype | No additional procedure risk |
| Whole Exome/Genome Sequencing | On CVS/amnio samples | Single-gene disorders, rare syndromes | No additional procedure risk |
| Preimplantation Genetic Testing (PGT-A) | Before embryo transfer (IVF) | Aneuploidy screening in AMA with IVF | Applied to embryos before transfer |
Down Syndrome Risk by Maternal Age (from Emery's Genetics textbook)
| Maternal Age | Risk of Down Syndrome |
|---|---|
| 20 | 1 in 1,500 |
| 25 | 1 in 1,350 |
| 30 | 1 in 900 |
| 35 | 1 in 400 |
| 37 | 1 in 250 |
| 40 | 1 in 100 |
| 43 | 1 in 50 |
| 45 | 1 in 30 |
Quad Screen Pattern Summary
| Condition | AFP | hCG | uE3 | Inhibin A |
|---|---|---|---|---|
| Down Syndrome (T21) | Low | High | Low | High |
| Edwards Syndrome (T18) | Low | Low | Low | Normal |
| Neural Tube Defect | High | Normal | Normal | Normal |
| Smith-Lemli-Opitz | Normal | Normal | Very Low | Normal |
| Normal pregnancy | Normal | Normal | Normal | Normal |
(Source: Quick Compendium of Clinical Pathology, 5th ed.; Creasy & Resnik's Maternal-Fetal Medicine)
Key Clinical Pearls for AMA
- ACOG and SMFM recommend that all pregnant women (regardless of age) be counseled about prenatal genetic screening options - not just those ≥35.
- A positive NIPT result is a screen, not a diagnosis - invasive confirmation (CVS or amniocentesis) is needed before clinical decisions.
- Trisomy 21 and trisomy 18 risk increase with age by OR ~1.18 per year after 35.
- Trisomy 13, Turner syndrome, Klinefelter syndrome, and structural chromosomal abnormalities do not show a significant correlation with maternal age.
- Women ≥35 using IVF can benefit from PGT-A (preimplantation genetic testing for aneuploidy) to select euploid embryos.
- Chromosomal microarray on CVS/amnio samples detects submicroscopic copy number variants (microdeletions/duplications) that standard karyotyping misses.
Sources: Creasy & Resnik's Maternal-Fetal Medicine; Emery's Elements of Medical Genetics and Genomics; Thompson & Thompson Genetics and Genomics in Medicine, 9th ed.; Quick Compendium of Clinical Pathology, 5th ed.; Harrison's Principles of Internal Medicine 22E
This is a shared conversation. Sign in to Orris to start your own chat.